Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
SM Radiology Journal
|
May 10, 2016
IDH1 Mutations in Glioma: Considerations for Radiotracer Development
Satish K Chitneni
ACS Medicinal Chemistry Letters
|
July 24, 2018
Synthesis and Evaluation of a <sup>18</sup>F-Labeled Triazinediamine Analogue for Imaging Mutant IDH1 Expression in Gliomas by PET
Satish K Chitneni, Hai Yan, Michael R Zalutsky
Molecular Pharmaceutics
|
September 15, 2021
Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation
Zhengyuan Zhou, Michael R Zalutsky, Satish K Chitneni
Bioorganic & Medicinal Chemistry Letters
|
April 18, 2022
Stapled peptides as scaffolds for developing radiotracers for intracellular targets: Preliminary evaluation of a radioiodinated MDM2-binding stapled peptide in the SJSA-1 osteosarcoma model
Zhengyuan Zhou, Michael R Zalutsky, Satish K Chitneni
European Journal of Medicinal Chemistry
|
April 10, 2026
Synthesis and evaluation of RG7388-based fluorinated MDM2 inhibitors for developing <sup>18</sup>F-labeled probes for PET imaging
Atchimnaidu Siriki, Zhengyuan Zhou, Graham Ragland, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 6, 2025
A concise review on MDM2 inhibitors and recent progress in radiopharmaceutical development for imaging MDM2 expression in tumors with PET or SPECT
Atchimnaidu Siriki, Graham Ragland, Janardhan Vasireddy, et al.
Molecules (Basel, Switzerland)
|
November 2, 2019
Observations on the Effects of Residualization and Dehalogenation on the Utility of <i>N</i>-Succinimidyl Ester Acylation Agents for Radioiodination of the Internalizing Antibody Trastuzumab
Satish K Chitneni, Eftychia Koumarianou, Ganesan Vaidyanathan, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 30, 2021
Feasibility of Developing Radiotracers for MDM2: Synthesis and Preliminary Evaluation of an <sup>18</sup>F-Labeled Analogue of the MDM2 Inhibitor SP-141
Satish K Chitneni, Zhengyuan Zhou, Brian E Watts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 15, 2011
Molecular imaging of hypoxia
Satish K Chitneni, Gregory M Palmer, Michael R Zalutsky, et al.
Bioorganic & Medicinal Chemistry
|
March 15, 2018
Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation
Zhengyuan Zhou, Satish K Chitneni, Nick Devoogdt, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
SM Radiology Journal
|
May 10, 2016
IDH1 Mutations in Glioma: Considerations for Radiotracer Development
Satish K Chitneni
ACS Medicinal Chemistry Letters
|
July 24, 2018
Synthesis and Evaluation of a <sup>18</sup>F-Labeled Triazinediamine Analogue for Imaging Mutant IDH1 Expression in Gliomas by PET
Satish K Chitneni, Hai Yan, Michael R Zalutsky
Molecular Pharmaceutics
|
September 15, 2021
Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation
Zhengyuan Zhou, Michael R Zalutsky, Satish K Chitneni
Bioorganic & Medicinal Chemistry Letters
|
April 18, 2022
Stapled peptides as scaffolds for developing radiotracers for intracellular targets: Preliminary evaluation of a radioiodinated MDM2-binding stapled peptide in the SJSA-1 osteosarcoma model
Zhengyuan Zhou, Michael R Zalutsky, Satish K Chitneni
European Journal of Medicinal Chemistry
|
April 10, 2026
Synthesis and evaluation of RG7388-based fluorinated MDM2 inhibitors for developing <sup>18</sup>F-labeled probes for PET imaging
Atchimnaidu Siriki, Zhengyuan Zhou, Graham Ragland, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 6, 2025
A concise review on MDM2 inhibitors and recent progress in radiopharmaceutical development for imaging MDM2 expression in tumors with PET or SPECT
Atchimnaidu Siriki, Graham Ragland, Janardhan Vasireddy, et al.
Molecules (Basel, Switzerland)
|
November 2, 2019
Observations on the Effects of Residualization and Dehalogenation on the Utility of <i>N</i>-Succinimidyl Ester Acylation Agents for Radioiodination of the Internalizing Antibody Trastuzumab
Satish K Chitneni, Eftychia Koumarianou, Ganesan Vaidyanathan, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 30, 2021
Feasibility of Developing Radiotracers for MDM2: Synthesis and Preliminary Evaluation of an <sup>18</sup>F-Labeled Analogue of the MDM2 Inhibitor SP-141
Satish K Chitneni, Zhengyuan Zhou, Brian E Watts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 15, 2011
Molecular imaging of hypoxia
Satish K Chitneni, Gregory M Palmer, Michael R Zalutsky, et al.
Bioorganic & Medicinal Chemistry
|
March 15, 2018
Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation
Zhengyuan Zhou, Satish K Chitneni, Nick Devoogdt, et al.
Page
of 4